By Graciela L. on October 17, 2021 at 2 p.m. Posted at 9:58 p.m.
It is a step forward in the fight against AIDS! Cabotegrovervir, which was marketed in the spring, will soon be available in France and will allow people to be treated for HIV every two months instead of daily pills.
Already available in the United States and Canada Kabotegravir In the spring, European marketing was approved. Good news for all patients VIH ! Hot Otorita de Sante estimates that treatment will be available by the end of the year Early 2022. L ‘Anti-virus drug allows you to drop the pill daily Vaccinate every two months.
But first you have to follow a Protocol Defined. For a month, the patient should follow oral double therapy. If all goes as planned, he could be transferred to a hospital nurse for the first three months and then every two months to an injectable form.
France is currently negotiating The price of this treatmentWith labs, it almost costs $ 43,560 for the first year in the United States. The French authorities want to make it as accessible as possible to HIV-infected patients so that it can be supplemented by social security.
68% of people with HIV want to try Vaccine treatment2020 According to a European-wide study. Patients’ lives are made easier by the arrival of Cabotegravir. Lenakapavir, a treatment that can be injected every six months with intradermal transplants, is still being studied.